Complex encounters: Nanoparticles in whole blood and their uptake into different types of white blood cells

Nanomedicine

Volumn 8, Issue 5, 2013, Pages 699-713

  Baumann, Daniela ^a   Hofmann, Daniel ^a   Nullmeier, Sven ^b   Panther, Patricia ^b   Dietze, Claudia ^a   Musyanovych, Anna ^a   Ritz, Sandra ^a   Landfester, Katharina ^a   Mailänder, Volker ^a,c  

^a MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

B cell; cellular uptake; EDTA; heparin; leukocytes; monocytes; nanoparticle; neutrophil granulocytes; T cell; whole blood

Indexed keywords

ACRYLIC ACID; CELL SURFACE MARKER; CETRIMONIUM CHLORIDE; DODECYL SULFATE SODIUM; EDETIC ACID; HEPARIN; METHACRYLIC ACID 2 AMINOETHYL ESTER; NANOPARTICLE; STYRENE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BLOOD SAMPLING; CELL CULTURE; CELL TYPE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANTICOAGULANTS; EDETIC ACID; FLOW CYTOMETRY; HEPARIN; HUMANS; LEUKOCYTES; NANOPARTICLES; POLYSTYRENES;

EID: 84877669643     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.111     Document Type: Article

References (43)

1. Dobrovolskaia MA, Aggarwal P, Hall JB, Mcneil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 5(4), 487-495 (2008).
2. He Q, Zhang J, Shi J et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 31(6), 1085-1092 (2010).
3. Labarre D, Vauthier C, Chauvierre C, Petri B, Müller R, Chehimi MM. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26(24), 5075-5084 (2005).
4. Beduneau A, Ma Z, Grotepas CB et al. Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One 4(2), e4343 (2009).
5. Lunov O, Syrovets T, Loos C et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5(3), 1657-1669 (2011).
6. Mailander V, Landfester K. Interaction of nanoparticles with cells. Biomacromolecules 10(9), 2379-2400 (2009).
7. Nowacek AS, Balkundi S, McMillan J et al. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. J. Control. Release 150(2), 204-211 (2011).
8. Blank F, Gerber P, Rothen-Rutishauser B et al. Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 5(4), 606-621 (2011).
9. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20(45), 455101 (2009).
10. Kim D, El-Shall H, Dennis D, Morey T. Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf. B Biointerfaces 40(2), 83-91 (2005).
11. Sahli H, Tapon-Bretaudiere J, Fischer AM et al. Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials 18(4), 281-288 (1997).
12. Adkins JN, Varnum SM, Auberry KJ et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell Proteomics 1(12), 947-955 (2002).
13. Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson KA. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31(36), 9511-9518 (2010).
14. Lundqvist M, Stigler J, Cedervall T et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5(9), 7503-7509 (2011).
15. Neun BW, Dobrovolskaia MA. Method for in vitro analysis of nanoparticle thrombogenic properties. Methods Mol. Biol. 697, 225-235 (2011).
16. Oslakovic C, Cedervall T, Linse S, Dahlback B. Polystyrene nanoparticles affecting blood coagulation. Nanomedicine 8(6), 981-986 (2011).
17. Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol. 40(14), 4353-4359 (2006).
18. Clift MJ, Gehr P, Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch. Toxicol. 85(7), 723-731 (2011).
19. Weiss CK, Lorenz MR, Landfester K, Mailander V. Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Macromol. Biosci. 7(7), 883-896 (2007).
20. Weiss CK, Kohnle MV, Landfester K et al. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation. ChemMedChem 3(9), 1395-1403 (2008).
21. Lorenz MR, Kohnle MV, Dass M et al. Synthesis of fluorescent polyisoprene nanoparticles and their uptake into various cells. Macromol. Biosci. 8(8), 711-727 (2008).
22. Paiphansiri U, Dausend J, Musyanovych A, Mailander V, Landfester K. Fluorescent polyurethane nanocapsules prepared via inverse miniemulsion: surface functionalization for use as biocarriers. Macromol. Biosci. 9(6), 575-584 (2009).
23. Mailander V, Lorenz MR, Holzapfel V et al. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol. Imaging Biol. 10(3), 138-146 (2008).
24. Lorenz MR, Holzapfel V, Musyanovych A et al. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27(14), 2820-2828 (2006).
25. Zupke O, Distler E, Baumann D et al. Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticles. Biomaterials 31(27), 7086-7095 (2010).
26. Musyanovych A, Rossmanith R, Tontsch C, Landfester K. Effect of hydrophilic co-monomer and surfactant type on the colloidal stability and size distribution of carboxyl- and amino-functionalized polystyrene particles prepared by miniemulsion polymerization. Langmuir 23(10), 5367-5376 (2007).
27. Landfester K, Musyanovych A, Mailander V. From polymeric particles to multifunctional nanocapsules for biomedical applications using the miniemulsion process. J. Polym. Sci. Pol. Chem. 48(3), 493-515 (2010).
28. Jiang X, Dausend J, Hafner M et al. Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules 11(3), 748-753 (2010).
29. Jiang X, Musyanovych A, Rocker C, Landfester K, Mailander V, Nienhaus GU. Specific effects of surface carboxyl groups on anionic polystyrene particles in their interactions with mesenchymal stem cells. Nanoscale 3(5), 2028-2035 (2011).
30. Xia T, Kovochich M, Liong M, Zink JI, Nel AE. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2(1), 85-96 (2008).
31. Holzapfel V, Musyanovych A, Landfester K, Lorenz MR, Mailander V. Preparation of fluorescent carboxyl and amino functionalized polystyrene particles by miniemulsion polymerization as markers for cells. Macromol. Chem. Phys. 206(24), 2440-2449 (2005).
32. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology 258(2-3), 139-147 (2009).
33. Roy SC, Paulose M, Grimes CA. The effect of TiO2 nanotubes in the enhancement of blood clotting for the control of hemorrhage. Biomaterials 28(31), 4667-4672 (2007).
34. Tavano R, Segat D, Reddi E et al. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond.) 5(6), 881-896 (2010).
35. Shapiro HM. Practical Flow Cytometry. John Wiley & Sons, NY, USA, 274-280 (2003).
36. Nunes P, Demaurex N. The role of calcium signaling in phagocytosis. J. Leukoc. Biol. 88(1), 57-68 (2010).
37. Baba Y, Kurosaki T. Physiological function and molecular basis of STIM1-mediated calcium entry in immune cells. Immunol. Rev. 231(1), 174-188 (2009).
38. Landfester K, Musyanovych A, Mailander V. Polymeric nanoparticles as carrier systems: how does the material and surface charge affect cellular uptake? In: Clinical Chemistry Research. Mitchem BH, Sharnham CI (Eds). Nova Science Publishers Inc., NY, USA, 195-220 (2009).
39. Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9(2), 435-443 (2008).
40. Bartneck M, Keul HA, Wambach M et al. Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells. Nanomedicine doi:10.1016/j. nano.2012.02.012 (2012) (Epub ahead of print).
41. Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7(10), 1322-1337 (2011).
42. International Organization for Standardization. Nanotechnologies - Terminology and definitions for nano-objects - Nanoparticle, nanofibre and nanoplate www.iso.org/iso/catalogue-detail?csnumber=44278
43. European Commission. Scientific Committee on Emerging and Newly Identified Health Risks. http://ec.europa.eu/health/scientific-committees/ publications/index-en.htm